Among RPG group companies, which include some well-known names such as Ceat and Kec International, RPG Life Sciences is the least known. However, of late, promoter and group chairman Harsh Goenka has been increasing his stake through open-market transactions. Over the past one month, Goenka increased his personal stake from 0.22 % to 2.3 % at an average price of ₹96. The total promoter holding in the company is around 62% with zero pledge. RPG Life, with an over ₹190 crore market cap and a turnover of ₹244 crore, offers a range of high-value synthetic API in the general therapeutic category. With a presence in Europe, Latin America and Asia, the company is now foraying into the US markets. Over the years, its debt has reduced amid rising profits. In FY14, profit jumped 12-fold to ₹53 crore. At a time when operating performance is improving, Goenka’s market action indicates that the best is yet to come.
Good tidings in store
Harsh Goenka has been increasing his stake in RPG Life through open-market transactions
You don’t want to be left behind. Do you?
Our work is exclusively for discerning readers. To read our edgy stories and access our archives, you’ve to subscribe
To make this market exuberant enough for a bust will take considerably higher prices
Companies that maximise per share value, even if they don't grow will be great bets
Once we get over all this macho 'I can do everything on my own' nonsense, Life is much better
Engines of 'influence' work exactly the way power flows when you flip a switch
You want to see a business model that makes sense now; it is hard to change later on